about
Biomarkers in preclinical cancer imaging.Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells.Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?Cell tracking in cardiac repair: what to image and how to image.Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label.Compartmentalization of Gd liposomes: the quenching effect explained.Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRINanoparticles and clinically applicable cell tracking.On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.Computed tomography and magnetic resonance imaging.The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.Radiolabeling polymeric micelles for in vivo evaluation: a novel, fast, and facile method.Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.Encapsulation of allogeneic mesenchymal stem cells in alginate extends local presence and therapeutic function.In vivo quantitative assessment of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging.Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.T1 mapping in the rat myocardium at 7 tesla using a modified CINE inversion recovery sequence.Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI.Labelling of mammalian cells for visualisation by MRI.Intravenous and intratumoral injection of Pluronic P94: The effect of administration route on biodistribution and tumor retention.Mesenchymal stem cells reduce pain but not degenerative changes in a mono-iodoacetate rat model of osteoarthritis.In vivo MRI mapping of iron oxide-labeled stem cells transplanted in the heart.Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE.Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT.Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanomaSPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressuresMesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis modelIn situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patientsImmunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical OutcomePerspectives on Small Animal Radionuclide Imaging; Considerations and Advances in AtherosclerosisMultiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue
P50
Q30416864-C36332AE-168F-41EB-92CA-EC0B9263FC51Q31034293-E14158CF-C888-4B3E-830A-B8253F3BB812Q35015049-BD170EF2-A0AC-4A43-8A86-A9AC48A0A8A9Q35589728-6E1481A2-FD9E-4606-A79F-B3DE3A5CF47EQ35783485-3EE352BB-1B3F-45CB-A73A-C7334A4C492DQ35805404-0CE3D892-D63A-404D-83A5-2E06A40F5636Q36265194-0B1CC804-0C1D-48F1-8C8E-990B8525B908Q36464131-06DB18E6-269E-4B99-9AD7-0C2FAF851BB3Q36514508-647B5335-3C8A-4298-90F0-0A84C202D523Q37354975-6A905B62-9FA5-4F77-8995-27A2C7A33FA6Q38062415-16B0AA9D-65D4-46D8-B022-ABB0C40F63AAQ38217493-09FCB0AC-33E1-470A-96A0-C12DB29D3107Q38327170-2EB105E0-3873-405A-BB52-A98F8F9191F0Q38774584-BEB3ADDB-2636-4FD3-B6CA-74AF00C61ADAQ38990557-019F1F65-94B6-4053-8F1C-D0F18FFBD378Q39217789-5F784958-3DE0-440D-B54D-6B28FE662185Q40917724-54675D2A-DBA5-41D0-8EC7-83963577B9FFQ42345704-8C5F809B-6A26-4493-A8E7-7B6668A459F8Q43506229-6C6D67FD-3991-461E-90C9-7F1A0AB95732Q48832721-AF40C44C-BB86-4621-80B6-7BD978348166Q48841689-9D014840-7AB7-4456-83B2-4F628F44922BQ49092525-21B99BA5-7DF3-4F04-B7E1-60D75EB4BA29Q50617273-2D1C4023-A8E5-4625-B86A-BCBA6CD38020Q50625476-6ECB876B-FBE7-4D61-962B-BD61D12CCEACQ52568126-31BF7212-246F-42B9-B84E-31DB798A706AQ52656807-615DF8A6-E862-4BF1-8DE9-0DEDF93C4D6BQ54649054-D0AEE570-5C1B-4D09-9C69-737C4B4D7B0AQ56895314-8383A477-9096-4EF1-91B7-931142FD353CQ57154180-633D81D9-A841-4458-B7C5-E8DC04506FC4Q58606688-5A506438-1B1E-4125-A550-57030FDA616FQ58619995-6AFDB942-FA3E-4E16-AB21-8AB5BD13B256Q58620035-63625527-171E-4C6F-9440-59244BBF2D7DQ64107238-B1E7ABEA-E1AF-4F84-A105-B43EAA14A25AQ81406797-F46EFF4D-2CE4-43B5-B61D-4B7770BB3BA7
P50
description
researcher
@en
wetenschapper
@nl
name
Monique R Bernsen
@en
Monique R Bernsen
@nl
type
label
Monique R Bernsen
@en
Monique R Bernsen
@nl
prefLabel
Monique R Bernsen
@en
Monique R Bernsen
@nl
P106
P108
P31
P496
0000-0002-5203-5083